Treatment with elafibranor to normalize alkaline phosphatase in patients with primary biliary cholangitis and incomplete response to ursodeoxycholic acid: Results from the phase III randomized controlled ELSPIRE trial.

Kris V Kowdley, Eric Lawitz, Christopher L Bowlus, Kuldeep Cheent, Matthieu Guivarch, Vaclav Hejda, Jeong Heo, Byoung K Jang, Wonseok Kang, Carmen Landaverde, Anna S Lok, Ashis Mukhopadhya, Antonio Olveira, Bhaktasharan Patel, Fabian Rodas Ochoa, Sergio Rodríguez-Tajes, Jan Sperl, Frank E Uschner, Ziad Younes, Gillian Bubb, Valeria Cranham, George Harb, Claire Raskino, Philip J F Troke, Benjamin Miller, Ana Lleo, ELSPIRE Trial Investigators’ Group

DOI: 10.1097/hep.0000000000001906

На странице источника доступны аннотация, полный текст или сведения о том, где его прочитать.